Clostridium difficile infection: An overview of the disease and its pathogenesis, epidemiology and interventions
- PMID: 21327030
- PMCID: PMC3023605
- DOI: 10.4161/gmic.1.4.12706
Clostridium difficile infection: An overview of the disease and its pathogenesis, epidemiology and interventions
Abstract
Clostridium difficile infection (CDI) is the primary cause of antibiotic-associated diarrhea and is a significant nosocomial disease. In the past ten years, variant toxin-producing strains of C. difficile have emerged, that have been associated with severe disease as well as outbreaks worldwide. This review summarizes current information on C. difficile pathogenesis and disease, and highlights interventions used to combat single and recurrent episodes of CDI.
References
-
- McFarland LV. Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections. Anaerobe. 2009;15:274–280. - PubMed
-
- Dubberke ER, Wertheimer AI. Review of current literature on the economic burden of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2009;30:57–66. - PubMed
-
- O'Brien JA, Lahue BJ, Caro JJ, Davidson DM. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol. 2007;28:1219–1227. - PubMed
-
- O'Connor JR, Johnson S, Gerding DN. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology. 2009;136:1913–1924. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous